AMERICAN PHARMACISTS ASSOCIATIONPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$162,590,387
Investments
47%
Property, Plant, & Equipment (net)
33%
Cash & Equivalents
10%
Receivables (Non-Related)
7%
Other Assets
2%
Prepaid Expenses
<1%
Inventories
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$121,802,311
Notes Payable / Debt (Non-Related)
85%
Payables & Accruals
5%
Deferred Revenue
5%
Other Liabilities
4%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$16,246,623
$15,643,732
-4%
Receivables (Non-Related)
$13,924,592
$11,647,994
-16%
Related-Party Receivables
-
-
-
Inventories
$166,377
$154,898
-7%
Prepaid Expenses
$940,553
$1,144,816
+22%
Investments
$67,927,519
$77,131,688
+14%
Property, Plant, & Equipment (net)
$55,936,662
$54,384,105
-3%
Other Assets
$2,574,644
$2,483,154
-4%
Total Assets
$157,716,970
$162,590,387
+3%
Liabilities
2023
2024
Change
Payables & Accruals
$5,615,738
$6,420,002
+14%
Grants Payable
-
-
-
Deferred Revenue
$5,395,336
$6,279,063
+16%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$106,406,341
$104,123,897
-2%
Related-Party Payables
-
-
-
Other Liabilities
$4,910,926
$4,979,349
+1%
Total Liabilities
$122,328,341
$121,802,311
0%
Net assets
2023
2024
Change
Restricted Net Assets
$147,569
$149,526
+1%
Unrestricted Net Assets
$35,241,060
$40,638,550
+15%
Net assets
2023
2024
Change
Net assets
+$35,388,629
+$40,788,076
+15%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)